Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

644 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
Zanatta E, Cocconcelli E, Castelli G, Giraudo C, Fraia AS, De Zorzi E, Gatto M, Ienna L, Treppo E, Malandrino D, Cereser L, Emmi G, Giannelli F, Bellani S, Martini A, Moccaldi B, Ghirardello A, Avouac J, Quartuccio L, Allanore Y, Doria A, Spagnolo P, Balestro E, Iaccarino L. Zanatta E, et al. Among authors: spagnolo p. RMD Open. 2023 Aug;9(3):e003121. doi: 10.1136/rmdopen-2023-003121. RMD Open. 2023. PMID: 37541742 Free PMC article.
Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.
Balestro E, Calabrese F, Turato G, Lunardi F, Bazzan E, Marulli G, Biondini D, Rossi E, Sanduzzi A, Rea F, Rigobello C, Gregori D, Baraldo S, Spagnolo P, Cosio MG, Saetta M. Balestro E, et al. Among authors: spagnolo p. PLoS One. 2016 May 9;11(5):e0154516. doi: 10.1371/journal.pone.0154516. eCollection 2016. PLoS One. 2016. PMID: 27159038 Free PMC article.
Biopsy in idiopathic pulmonary fibrosis: back to the future.
Rossi G, Spagnolo P. Rossi G, et al. Among authors: spagnolo p. Expert Rev Respir Med. 2017 Sep;11(9):679-684. doi: 10.1080/17476348.2017.1351302. Epub 2017 Jul 10. Expert Rev Respir Med. 2017. PMID: 28673104 Review.
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis.
Harari S, Caminati A, Poletti V, Confalonieri M, Gasparini S, Lacedonia D, Luppi F, Pesci A, Sebastiani A, Spagnolo P, Vancheri C, Balestro E, Bonifazi M, Cerri S, De Giacomi F, Della Porta R, Foschino Barbaro MP, Fui A, Pasquinelli P, Rosso R, Tomassetti S, Specchia C, Rottoli P; for the ILDINET (Interstitial Lung Diseases Italian Network). Harari S, et al. Among authors: spagnolo p. Respiration. 2018;95(6):433-440. doi: 10.1159/000487711. Epub 2018 Mar 27. Respiration. 2018. PMID: 29587263 Free article.
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis.
Biondini D, Balestro E, Lacedonia D, Cerri S, Milaneschi R, Luppi F, Cocconcelli E, Bazzan E, Clini E, Foschino Barbaro MP, Gregori D, Cosio MG, Saetta M, Spagnolo P. Biondini D, et al. Among authors: spagnolo p. Sci Rep. 2018 Apr 13;8(1):5961. doi: 10.1038/s41598-018-24303-4. Sci Rep. 2018. PMID: 29654244 Free PMC article.
644 results